mastodon.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
The original server operated by the Mastodon gGmbH non-profit

Administered by:

Server stats:

331K
active users

#pbm

1 post1 participant0 posts today
Stuffed Crocodile<p><strong>En Garde!</strong></p><p><strong>Subtitle</strong>: </p><p><em>Being in the Main a Game of the Life and Times of a Gentleman Adventurer and his Several Companions</em></p><p>I was woefully ignorant about En Garde! (mind the exclamation mark) until recently, when I tried to investigate why this roleplaying game seems so popular for play-by-mail games, despite being mostly forgotten in normal tabletop RPG circles.</p><p>It’s to the point that Margam Evans currently publishes the 4th edition of the game, which is nearly unchanged from the 2nd edition from 1977, which itself was not such a leap from the 1st that came out in 1975.</p><p>Yes, this is one of the earliest published role-playing games after the original White Box came out, and it came out in the same year as Tunnels and Trolls, making it likely the third or fourth published rpg. And yet barely anyone talks about it.</p><p>When people writing about the history of the hobby write about it it will get a mention, and then not be discussed anymore. And the reason I think is quite simple: it is very much still a wargame, albeit one focused on single characters, and with a weirdly abstracted approach to actual war, and people noticed quickly that playing it at the table was not the best way to use the rules. En Garde! instead has been a mainstay of postal games (that is turn-based play by mail or play by post gaming) since it’s inception.</p><p>Now, other roleplaying games of the time dabbled in this as well. Dungeons and Dragons had postal games running, and a multitude of paid dungeon crawler games tried to bring the experience of DnD to people with no other local players available. Tunnels and Trolls was conceptualized as suited for postal games. En Garde! Likely came by it more by coincidence. It originally started as a system for sword duels, which did not actually use dice all that much*, instead accepting programmed written orders for the duel.</p><p>Fascinating as this was, a small roleplaying system was attached to it that gave a reason WHY any two presumably reasonable gentlemen on the streets of 17th ct. Paris might want to duel themselves. One might meet the other party on one’s mistresses’ doorstep for example. Or be treated a bit too familiar by someone with too low a station. Or be in a regiment the other onr considers an enemy.</p><p>In any case, <em>raison!</em></p><p>Soon enough it turned out that the tacked on roleplaying system that was supposed to supplement the duelling game was much more enjoyable than the duels themselves. It concerned swashbuckling, carousing, womanizing gentlemen in 17th century France, roughly in the vein of the Three Musketeers (especially the <a href="https://en.m.wikipedia.org/wiki/The_Three_Musketeers_(1973_live-action_film)" rel="nofollow noopener" target="_blank">1973 Richard Lester</a> film which still was in everyone’s memories).</p><p>Characters in En Garde! are gentlemen, but they are always trying to increase their social status. They do this in a variety of ways, from openly carousing expensive spirits (showing they have the money to do that), toadying to other characters (getting some of that reflected glory), up to enjoying female companionship. It’s never defined what you actually are DOING with with that female companion, important is only you are seen with a female companion.</p><p>Yes, the answer is likely sex, but the way the rules float around that issue you might just visit a very dedicated embroidery circle together. Especially as I don’t think it’s ever established one can only play men, just that female companionship is necessary.</p><p>In any case the important part of the game is being seen doing stuff that shows your character is wealthy, rich, and manly. You’re the sword-wielding It girl of Paris.</p><p>Every once in a while characters will come across one another in complicated situations, and demand satisfaction.</p><p>All of that ideally is being recorded and transmitted to the other players somehow. The rules do not actually specifiy how, but the main way as established is by society papers. And that’s basically where the roleplaying happens. At the end of every round the referee puts together a gossip sheet of rumors, statements, duel results, and messages between characters. Most established campaigns identify themselves via the name of their respective gossip rag. The Paris Tribune for example, or <em>Les Petites Bêtes Soyeuses</em>. The latter actually is an ongoing and paid continuation of a campaign that has run since 1986, and the GM went and bought the rights to En Garde! when the last publisher folded.</p><p>There are a few running games, although&nbsp; it definitely doesn’t seem to have the clout DnD or Tunnels and Trolls has. The <a href="https://www.engarde.co.uk/" rel="nofollow noopener" target="_blank">website</a> has a <a href="https://www.engarde.co.uk/games.html#Top" rel="nofollow noopener" target="_blank">list</a>, and you might notice that not all the games are set in 17th ct. France. Different DMs often use variations on the rules, or set the game somewhere else, from 18th ct. London to Glorantha or Mars.</p><p>They also use some other variations. A character might e.g. join the Church and rise in power there, marry, run a business, or any other sort of shenanigans.</p><p>I have been thinking of integrating this with my current DnD/LL game. Outside of the name (Brillon) and a few other tidbits, nothing about the capital of the kingdom my campaign is set in really was established. I think one easily could have a game where characters in an En Garde game would be sent to “the Borderlands” and have to deal with local issues. In fact, the Castellan of Burg Aberwacht (as well as the bailiff and the curate) might be appointments given to characters going “on </p><p>The main issue is that combat skill is rather different between both systems, meaning it might not map to one another 1 to 1.</p><p>Oh, and I either have to raise the tech level of Aberwacht, or drop the one for the En Garde part. After all En Garde is based on the Three MUSKETeers.</p><p>Have to think about it.</p><p></p><p><strong>Footnote</strong>:</p><p>*A survey of the rules shows there is a single mention of random dice-based determination of things in the main rules. </p><p><a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://gmkeros.wordpress.com/tag/engarde/" target="_blank">#engarde</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://gmkeros.wordpress.com/tag/pbm/" target="_blank">#pbm</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://gmkeros.wordpress.com/tag/rpg/" target="_blank">#rpg</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://gmkeros.wordpress.com/tag/ttrpg/" target="_blank">#ttrpg</a> <a rel="nofollow noopener" class="hashtag u-tag u-category" href="https://gmkeros.wordpress.com/tag/wargame/" target="_blank">#wargame</a></p>
Maggie Maybe<p>The problem with the WARNING is that because of PBMs these <a href="https://zeroes.ca/tags/counterfeit" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>counterfeit</span></a> products get distributed by pharmacies.</p><p>I don’t remember if it’s retail pharmacies or facility pharmacies where this kept happening, but there was a PBS Frontline documentary about how PBMs cause counterfeit medication to appear in legitimate supply chains. </p><p>So how would any of us know?? </p><p><a href="https://content.govdelivery.com/accounts/USFDA/bulletins/3db4ac9" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">content.govdelivery.com/accoun</span><span class="invisible">ts/USFDA/bulletins/3db4ac9</span></a> </p><p><a href="https://zeroes.ca/tags/FDA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>FDA</span></a> <a href="https://zeroes.ca/tags/recall" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>recall</span></a> (sort of)<br><a href="https://zeroes.ca/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> <a href="https://zeroes.ca/tags/counterfeitMeds" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>counterfeitMeds</span></a> <a href="https://zeroes.ca/tags/ozempic" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ozempic</span></a></p>
Rolando A. :mastodon:<p>Fotos antiguas de <a href="https://mastodon.social/tags/Jack" class="mention hashtag" rel="tag">#<span>Jack</span></a> <a href="https://mastodon.social/tags/PBM" class="mention hashtag" rel="tag">#<span>PBM</span></a> <a href="https://mastodon.social/tags/Malinois" class="mention hashtag" rel="tag">#<span>Malinois</span></a></p>
oleslav<p>Mój świeży singiel właśnie wylądował wszędzie, ale przede wszystkim zapraszam do słuchania i ściągania na bandcampie ☺️</p><p><a href="https://mastodon.social/tags/electronicmusic" class="mention hashtag" rel="tag">#<span>electronicmusic</span></a> <a href="https://mastodon.social/tags/dubstep" class="mention hashtag" rel="tag">#<span>dubstep</span></a> <a href="https://mastodon.social/tags/pbm" class="mention hashtag" rel="tag">#<span>pbm</span></a> <a href="https://mastodon.social/tags/idm" class="mention hashtag" rel="tag">#<span>idm</span></a> </p><p><a href="https://oleslav.bandcamp.com/track/into-pass-of-nihilway" target="_blank" rel="nofollow noopener" translate="no"><span class="invisible">https://</span><span class="ellipsis">oleslav.bandcamp.com/track/int</span><span class="invisible">o-pass-of-nihilway</span></a></p>
Catherine Collingwood Estes<p>If <a href="https://mstdn.social/tags/Texas" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Texas</span></a> finds a way to regulate <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> interactions with <a href="https://mstdn.social/tags/SelfFunded" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SelfFunded</span></a> employer <a href="https://mstdn.social/tags/HealthInsurance" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>HealthInsurance</span></a>, that could lead to a wide range of health care provider groups trying to adopt a similar strategy. <a href="https://mstdn.social/tags/ERISA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ERISA</span></a> <a href="https://mstdn.social/tags/Legislation" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Legislation</span></a> <a href="https://buff.ly/4gHuEsk" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/4gHuEsk</span><span class="invisible"></span></a></p>
Catherine Collingwood Estes<p>The appointment is the latest in a series of executive changes at <a href="https://mstdn.social/tags/CVSHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CVSHealth</span></a>. <a href="https://mstdn.social/tags/Caremark" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Caremark</span></a> <a href="https://mstdn.social/tags/CVS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CVS</span></a> <a href="https://mstdn.social/tags/ExecutiveShuffle" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ExecutiveShuffle</span></a> <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> <a href="https://buff.ly/4kfCf4u" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/4kfCf4u</span><span class="invisible"></span></a></p>
Catherine Collingwood Estes<p>Multiple <a href="https://mstdn.social/tags/bipartisan" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>bipartisan</span></a> bills have been advanced that support the underlying goal of addressing anticompetitive, anti-consumer practices employed by <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a>. <a href="https://mstdn.social/tags/Monopolies" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Monopolies</span></a> <a href="https://mstdn.social/tags/Rx" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Rx</span></a> <a href="https://mstdn.social/tags/prescriptions" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>prescriptions</span></a> <a href="https://mstdn.social/tags/Congress" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Congress</span></a> <a href="https://mstdn.social/tags/legislation" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>legislation</span></a> <a href="https://buff.ly/3WVE0tx" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/3WVE0tx</span><span class="invisible"></span></a></p>
Catherine Collingwood Estes<p>The <a href="https://mstdn.social/tags/Texas" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Texas</span></a> <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> laws should escape <a href="https://mstdn.social/tags/ERISA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ERISA</span></a> preemption because the laws do not refer to ERISA plans, dictate ERISA plan choices or add requirements to ERISA plan beneficiary status. <a href="https://mstdn.social/tags/AttorneyGeneral" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>AttorneyGeneral</span></a> <a href="https://mstdn.social/tags/opinion" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>opinion</span></a> <a href="https://mstdn.social/tags/Rx" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Rx</span></a> <a href="https://buff.ly/3EBx7am" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/3EBx7am</span><span class="invisible"></span></a></p>
Catherine Collingwood Estes<p><a href="https://mstdn.social/tags/ExpressScripts" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ExpressScripts</span></a> intends to make new steps standard operating procedure moving forward, creating a baseline for its efforts around <a href="https://mstdn.social/tags/transparency" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>transparency</span></a> and <a href="https://mstdn.social/tags/affordability" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>affordability</span></a>. <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> <a href="https://mstdn.social/tags/Prescriptions" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Prescriptions</span></a> <a href="https://buff.ly/3EfpIxv" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/3EfpIxv</span><span class="invisible"></span></a></p>
oleslav<p>small sneak peek at my new album i&#39;m working on</p><p><a href="https://mastodon.social/tags/dubstep" class="mention hashtag" rel="tag">#<span>dubstep</span></a> <a href="https://mastodon.social/tags/bassmusic" class="mention hashtag" rel="tag">#<span>bassmusic</span></a> <a href="https://mastodon.social/tags/polishbassmusic" class="mention hashtag" rel="tag">#<span>polishbassmusic</span></a> <a href="https://mastodon.social/tags/pbm" class="mention hashtag" rel="tag">#<span>pbm</span></a> <a href="https://mastodon.social/tags/electronicmusic" class="mention hashtag" rel="tag">#<span>electronicmusic</span></a></p>
oleslav<p>Cały dzień się zastanawiam, czy fajnie by było wymyślić jakiś hashtag (oczywiście później można by było zrobić cały serwer) którym byśmy mogli oznaczać lokalną basową scenę, żeby jakoś i zjednoczyć oraz wyróżnić w fediwersum. <br />Proponuję <a href="https://mastodon.social/tags/pbm" class="mention hashtag" rel="tag">#<span>pbm</span></a> aka polish bass music.<br />ALBO <a href="https://mastodon.social/tags/PW" class="mention hashtag" rel="tag">#<span>PW</span></a> aka Polskie Wiertarki</p>
Catherine Collingwood Estes<p>As <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> services have traditionally been dominated by large companies such as CVS Caremark, Express Scripts and OptumRx, <a href="https://mstdn.social/tags/healthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>healthcare</span></a> systems are starting to create alternatives. <a href="https://mstdn.social/tags/Prescriptions" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Prescriptions</span></a> <a href="https://buff.ly/4ayzuGS" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/4ayzuGS</span><span class="invisible"></span></a></p>
Esme Ralda<p>UnitedHealth y sus PBMs inflaron precios de medicamentos en más de un 1000%, según informe de la FTC <a href="https://mastodon.social/tags/negocios" class="mention hashtag" rel="tag">#<span>negocios</span></a> <a href="https://mastodon.social/tags/killbait" class="mention hashtag" rel="tag">#<span>killbait</span></a> <a href="https://mastodon.social/tags/medicamentos" class="mention hashtag" rel="tag">#<span>medicamentos</span></a> <a href="https://mastodon.social/tags/unitedhealth" class="mention hashtag" rel="tag">#<span>unitedhealth</span></a> <a href="https://mastodon.social/tags/pbm" class="mention hashtag" rel="tag">#<span>pbm</span></a> <a href="https://killbait.com/es/unitedhealth-y-sus-pbms-inflaron-precios-de-medicamentos-en-mas-de-un-1000-segun-informe-de-la-ftc" target="_blank" rel="nofollow noopener" translate="no"><span class="invisible">https://</span><span class="ellipsis">killbait.com/es/unitedhealth-y</span><span class="invisible">-sus-pbms-inflaron-precios-de-medicamentos-en-mas-de-un-1000-segun-informe-de-la-ftc</span></a></p>
Catherine Collingwood Estes<p>The <a href="https://mstdn.social/tags/SenateCommittee" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SenateCommittee</span></a> will continue to fight for pharmacy benefit manager oversight legislation in the coming year and may focus more on benefits access for independent contractors. <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> <a href="https://mstdn.social/tags/GigEconomy" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GigEconomy</span></a> <a href="https://buff.ly/3Clwe4Y" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/3Clwe4Y</span><span class="invisible"></span></a></p>
input.translation<p>"Gleevec, used to treat cancer, was marked up 5232% in commercial markets and the drug Adcirca, used to treat pulmonary hypertension, from 'an average of $27 in 2022' to '$2,106, on average, for a 30-day supply of the medication...an average markup of over 7,700 percent.'"</p><p><a href="https://www.psca.org/news/psca-news/2025/1/ftc-finds-pbms-massively-mark-up-prices-of-key-drugs/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">psca.org/news/psca-news/2025/1</span><span class="invisible">/ftc-finds-pbms-massively-mark-up-prices-of-key-drugs/</span></a></p><p><a href="https://ieji.de/tags/UnitedHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>UnitedHealth</span></a> <a href="https://ieji.de/tags/healthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>healthcare</span></a> <a href="https://ieji.de/tags/healthinsurance" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>healthinsurance</span></a> <a href="https://ieji.de/tags/insurance" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>insurance</span></a> <a href="https://ieji.de/tags/ACA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ACA</span></a> <a href="https://ieji.de/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> <a href="https://ieji.de/tags/FTC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>FTC</span></a> <a href="https://ieji.de/tags/pricegouging" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pricegouging</span></a> <a href="https://ieji.de/tags/brianthompson" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>brianthompson</span></a> <a href="https://ieji.de/tags/bigpharma" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>bigpharma</span></a></p>
smeg<p>PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC<br><a href="https://thehill.com/policy/healthcare/5085119-ftc-report-pharmacy-benefit-managers/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">thehill.com/policy/healthcare/</span><span class="invisible">5085119-ftc-report-pharmacy-benefit-managers/</span></a></p><p><a href="https://assortedflotsam.com/tags/pbm" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pbm</span></a> <a href="https://assortedflotsam.com/tags/pbms" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pbms</span></a> <a href="https://assortedflotsam.com/tags/PBMreform" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBMreform</span></a> <a href="https://assortedflotsam.com/tags/cigna" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>cigna</span></a> <a href="https://assortedflotsam.com/tags/unitedhealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>unitedhealth</span></a> <a href="https://assortedflotsam.com/tags/prescriptions" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>prescriptions</span></a> <a href="https://assortedflotsam.com/tags/pharmacybenefitmanagers" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pharmacybenefitmanagers</span></a> <a href="https://assortedflotsam.com/tags/cvs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>cvs</span></a> <a href="https://assortedflotsam.com/tags/caremark" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>caremark</span></a> <a href="https://assortedflotsam.com/tags/ushealthcarecosts" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ushealthcarecosts</span></a> <a href="https://assortedflotsam.com/tags/ushealthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ushealthcare</span></a> <a href="https://assortedflotsam.com/tags/healthinsurance" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>healthinsurance</span></a></p>
Catherine Collingwood Estes<p>The FTC's findings also indicate that these <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> earned an estimated $1.4 billion of income by charging their plan sponsor clients more than they reimburse <a href="https://mstdn.social/tags/pharmacies" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pharmacies</span></a> for the <a href="https://mstdn.social/tags/drugs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>drugs</span></a>. <a href="https://mstdn.social/tags/MedicalCosts" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>MedicalCosts</span></a> <a href="https://mstdn.social/tags/prescriptions" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>prescriptions</span></a> <a href="https://buff.ly/4aj9dfE" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/4aj9dfE</span><span class="invisible"></span></a></p>
Howard Smith MD, AM<p>Plant-based Burgers May Depress You. <a href="https://masto.nyc/tags/plantbasedmeats" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>plantbasedmeats</span></a> <a href="https://masto.nyc/tags/pbm" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pbm</span></a> <a href="https://masto.nyc/tags/vegetarian" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>vegetarian</span></a> <a href="https://masto.nyc/tags/ultraprocessed" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ultraprocessed</span></a><br><a href="https://www.instagram.com/reel/DEne0YfsmK4/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">instagram.com/reel/DEne0YfsmK4</span><span class="invisible">/</span></a></p>
1 tripod in 3 trenchcoats<p>I now decided to create a secret auction in the <a href="https://dice.camp/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> <a href="https://dice.camp/tags/dnd" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>dnd</span></a> game I play in. For added secrecy I decided to run it in the depths of our local <a href="https://dice.camp/tags/usenet" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>usenet</span></a> groups, to model having it in some remote dungeon somewhere.</p>
Catherine Collingwood Estes<p>The big <a href="https://mstdn.social/tags/PBM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PBM</span></a> say their buying power and exclusive access to information enable them to save money for stakeholders. Critics say they are skimming from the drug market, perhaps $100 billion a year. <a href="https://mstdn.social/tags/ERISA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ERISA</span></a> <a href="https://mstdn.social/tags/lawsuits" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>lawsuits</span></a> <a href="https://mstdn.social/tags/EmployerPlans" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>EmployerPlans</span></a> <a href="https://mstdn.social/tags/FiduciaryDuty" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>FiduciaryDuty</span></a> <a href="https://buff.ly/4gK29L7" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">buff.ly/4gK29L7</span><span class="invisible"></span></a></p>